Steven Cohen’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Other funds holding CSTL
Steven Cohen's CSTL Position: Q3 2026 in Review
Steven Cohen sold out of Castle Biosciences (CSTL) in Q3 2026, closing a stake of 357,317 shares — an estimated $8.52M sold.
Steven Cohen first reported a position in CSTL in Q1 2020 and held it in 16 quarters. The position peaked at $28M in Q1 2022. 202 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.
- Steven Cohen reported no remaining Castle Biosciences position as of Q3 2026 after selling out during the quarter.
- Steven Cohen sold 357,317 Castle Biosciences shares in Q3 2026, an estimated $8.52M.
- Steven Cohen first reported a position in Castle Biosciences in Q1 2020 and held it in 16 quarters.
- Steven Cohen's Castle Biosciences position peaked at $28M in Q1 2022.
- 202 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.